Your browser doesn't support javascript.
loading
Predictors of Remission and Low Disease Activity State in Systemic Lupus Erythematosus: Data from a Multiethnic, Multinational Latin American Cohort.
Ugarte-Gil, Manuel F; Wojdyla, Daniel; Pons-Estel, Guillermo J; Quintana, Rosana; Gómez-Puerta, José A; Catoggio, Luis J; Alvarellos, Alejandro; Saurit, Verónica; Borba, Eduardo; Sato, Emilia; Costallat, Lilian; Da Silva, Nilzio A; Iglesias-Gamarra, Antonio; Neira, Oscar; Reyes-Llerena, Gil; Cardiel, Mario H; Amigo, Mary Carmen; Acevedo-Vásquez, Eduardo; Esteva-Spinetti, María H; Alarcón, Graciela S; Pons-Estel, Bernardo A.
Afiliação
  • Ugarte-Gil MF; From the Department of Rheumatology, Hospital Guillermo Almenara Irigoyen, EsSalud; Universidad Científica del Sur, Lima, Peru; Grupo Latino Americano De Estudio de Lupus (GLADEL), Rosario, Argentina; Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Spain; Centro Regional de Enfermedad
  • Wojdyla D; M.F. Ugarte-Gil, MD, MSc, Department of Rheumatology, Hospital Guillermo Almenara Irigoyen, Universidad Científica del Sur; D. Wojdyla, MSc, GLADEL Consultant; G.J. Pons-Estel, MD, PhD, Department of Autoimmune Diseases, Hospital Clinic, and CREAR, Grupo Oroño; R. Quintana, MD, PhD, CREAR, Grupo Oro
  • Pons-Estel GJ; From the Department of Rheumatology, Hospital Guillermo Almenara Irigoyen, EsSalud; Universidad Científica del Sur, Lima, Peru; Grupo Latino Americano De Estudio de Lupus (GLADEL), Rosario, Argentina; Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Spain; Centro Regional de Enfermedad
  • Quintana R; M.F. Ugarte-Gil, MD, MSc, Department of Rheumatology, Hospital Guillermo Almenara Irigoyen, Universidad Científica del Sur; D. Wojdyla, MSc, GLADEL Consultant; G.J. Pons-Estel, MD, PhD, Department of Autoimmune Diseases, Hospital Clinic, and CREAR, Grupo Oroño; R. Quintana, MD, PhD, CREAR, Grupo Oro
  • Gómez-Puerta JA; From the Department of Rheumatology, Hospital Guillermo Almenara Irigoyen, EsSalud; Universidad Científica del Sur, Lima, Peru; Grupo Latino Americano De Estudio de Lupus (GLADEL), Rosario, Argentina; Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Spain; Centro Regional de Enfermedad
  • Catoggio LJ; M.F. Ugarte-Gil, MD, MSc, Department of Rheumatology, Hospital Guillermo Almenara Irigoyen, Universidad Científica del Sur; D. Wojdyla, MSc, GLADEL Consultant; G.J. Pons-Estel, MD, PhD, Department of Autoimmune Diseases, Hospital Clinic, and CREAR, Grupo Oroño; R. Quintana, MD, PhD, CREAR, Grupo Oro
  • Alvarellos A; From the Department of Rheumatology, Hospital Guillermo Almenara Irigoyen, EsSalud; Universidad Científica del Sur, Lima, Peru; Grupo Latino Americano De Estudio de Lupus (GLADEL), Rosario, Argentina; Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Spain; Centro Regional de Enfermedad
  • Saurit V; M.F. Ugarte-Gil, MD, MSc, Department of Rheumatology, Hospital Guillermo Almenara Irigoyen, Universidad Científica del Sur; D. Wojdyla, MSc, GLADEL Consultant; G.J. Pons-Estel, MD, PhD, Department of Autoimmune Diseases, Hospital Clinic, and CREAR, Grupo Oroño; R. Quintana, MD, PhD, CREAR, Grupo Oro
  • Borba E; From the Department of Rheumatology, Hospital Guillermo Almenara Irigoyen, EsSalud; Universidad Científica del Sur, Lima, Peru; Grupo Latino Americano De Estudio de Lupus (GLADEL), Rosario, Argentina; Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Spain; Centro Regional de Enfermedad
  • Sato E; M.F. Ugarte-Gil, MD, MSc, Department of Rheumatology, Hospital Guillermo Almenara Irigoyen, Universidad Científica del Sur; D. Wojdyla, MSc, GLADEL Consultant; G.J. Pons-Estel, MD, PhD, Department of Autoimmune Diseases, Hospital Clinic, and CREAR, Grupo Oroño; R. Quintana, MD, PhD, CREAR, Grupo Oro
  • Costallat L; From the Department of Rheumatology, Hospital Guillermo Almenara Irigoyen, EsSalud; Universidad Científica del Sur, Lima, Peru; Grupo Latino Americano De Estudio de Lupus (GLADEL), Rosario, Argentina; Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Spain; Centro Regional de Enfermedad
  • Da Silva NA; M.F. Ugarte-Gil, MD, MSc, Department of Rheumatology, Hospital Guillermo Almenara Irigoyen, Universidad Científica del Sur; D. Wojdyla, MSc, GLADEL Consultant; G.J. Pons-Estel, MD, PhD, Department of Autoimmune Diseases, Hospital Clinic, and CREAR, Grupo Oroño; R. Quintana, MD, PhD, CREAR, Grupo Oro
  • Iglesias-Gamarra A; From the Department of Rheumatology, Hospital Guillermo Almenara Irigoyen, EsSalud; Universidad Científica del Sur, Lima, Peru; Grupo Latino Americano De Estudio de Lupus (GLADEL), Rosario, Argentina; Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Spain; Centro Regional de Enfermedad
  • Neira O; M.F. Ugarte-Gil, MD, MSc, Department of Rheumatology, Hospital Guillermo Almenara Irigoyen, Universidad Científica del Sur; D. Wojdyla, MSc, GLADEL Consultant; G.J. Pons-Estel, MD, PhD, Department of Autoimmune Diseases, Hospital Clinic, and CREAR, Grupo Oroño; R. Quintana, MD, PhD, CREAR, Grupo Oro
  • Reyes-Llerena G; From the Department of Rheumatology, Hospital Guillermo Almenara Irigoyen, EsSalud; Universidad Científica del Sur, Lima, Peru; Grupo Latino Americano De Estudio de Lupus (GLADEL), Rosario, Argentina; Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Spain; Centro Regional de Enfermedad
  • Cardiel MH; M.F. Ugarte-Gil, MD, MSc, Department of Rheumatology, Hospital Guillermo Almenara Irigoyen, Universidad Científica del Sur; D. Wojdyla, MSc, GLADEL Consultant; G.J. Pons-Estel, MD, PhD, Department of Autoimmune Diseases, Hospital Clinic, and CREAR, Grupo Oroño; R. Quintana, MD, PhD, CREAR, Grupo Oro
  • Amigo MC; From the Department of Rheumatology, Hospital Guillermo Almenara Irigoyen, EsSalud; Universidad Científica del Sur, Lima, Peru; Grupo Latino Americano De Estudio de Lupus (GLADEL), Rosario, Argentina; Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Spain; Centro Regional de Enfermedad
  • Acevedo-Vásquez E; M.F. Ugarte-Gil, MD, MSc, Department of Rheumatology, Hospital Guillermo Almenara Irigoyen, Universidad Científica del Sur; D. Wojdyla, MSc, GLADEL Consultant; G.J. Pons-Estel, MD, PhD, Department of Autoimmune Diseases, Hospital Clinic, and CREAR, Grupo Oroño; R. Quintana, MD, PhD, CREAR, Grupo Oro
  • Esteva-Spinetti MH; From the Department of Rheumatology, Hospital Guillermo Almenara Irigoyen, EsSalud; Universidad Científica del Sur, Lima, Peru; Grupo Latino Americano De Estudio de Lupus (GLADEL), Rosario, Argentina; Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Spain; Centro Regional de Enfermedad
  • Alarcón GS; M.F. Ugarte-Gil, MD, MSc, Department of Rheumatology, Hospital Guillermo Almenara Irigoyen, Universidad Científica del Sur; D. Wojdyla, MSc, GLADEL Consultant; G.J. Pons-Estel, MD, PhD, Department of Autoimmune Diseases, Hospital Clinic, and CREAR, Grupo Oroño; R. Quintana, MD, PhD, CREAR, Grupo Oro
  • Pons-Estel BA; From the Department of Rheumatology, Hospital Guillermo Almenara Irigoyen, EsSalud; Universidad Científica del Sur, Lima, Peru; Grupo Latino Americano De Estudio de Lupus (GLADEL), Rosario, Argentina; Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Spain; Centro Regional de Enfermedad
J Rheumatol ; 46(10): 1299-1308, 2019 10.
Article em En | MEDLINE | ID: mdl-30824636
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article